Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nonmyeloablative Allogeneic PBSC Transplantation in Older AML Patients
NCT00053014Phase 2Terminated
- Sponsor
- SWOG Cancer Research Network
- Start
- Apr 2003
- Primary completion
- Jun 2005
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of allogeneic peripheral blood progenitor cells in acute myeloid leukemia (AML), sponsored by SWOG Cancer Research Network. Started Apr 2003; status: terminated.
02
Drugs
allogeneic peripheral blood progenitor cells
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT00053014.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00053014.